Schedule 13G ownership disclosure
ROIVANT SCIENCES LTD SHS
Common Shares, par value $0.0000000341740141 per share · CUSIP: G76279101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SB Investment Advisers (UK) Limited
Shares: 62,057,537.00 · Class: 8.5%
- SoftBank Vision Fund L.P.
Shares: 62,057,537.00 · Class: 8.5%
- SVF Holdings (UK) LLP
Shares: 62,057,537.00 · Class: 8.5%
- SVF Investments (UK) Limited
Shares: 62,057,537.00 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006632
- Form type
- SCHEDULE 13G/A
- Filer
- Roivant Sciences Ltd.
- CIK
- CIK 1635088
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership